Immutep Limited Stock Investor Sentiment

PRRUF Stock  USD 0.24  0.00  0.00%   
Roughly 56% of Immutep's investor base is looking to short. The analysis of overall sentiment of trading Immutep Limited pink sheet suggests that many investors are alarmed at this time. Immutep's investor sentiment overview provides quick insight into current market opportunities from investing in Immutep Limited. The current market sentiment, together with Immutep's historical and current headlines, can help investors time the market. In addition, many technical investors use Immutep Limited stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Immutep pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Immutep daily returns and investor perception about the current price of Immutep Limited as well as its diversification or hedging effects on your existing portfolios.
  
few days ago at news.google.com         
Immutep Advances Novel Autoimmune Therapy with Phase I Trial - TipRanks.com - TipRanks
Google News at Macroaxis
few days ago at news.google.com         
Immutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registra...
Google News at Macroaxis
over a week ago at news.google.com         
Immutep Limited Short Interest Update - MarketBeat
Google News at Macroaxis
over two weeks ago at news.google.com         
Immutep Limited Short Interest Up 5.6 percent in March - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
Immutep Stock Passes Above Fifty Day Moving Average of 2.35 - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
Immutep Limited Is Breakeven Near - Yahoo Finance
Google News at Macroaxis
over a month ago at news.google.com         
Immutep Stock Crosses Above 50 Day Moving Average of 2.35 - Defense World
Google News at Macroaxis
over a month ago at news.google.com         
Cancer Focused Immuteps Stock Soars On Tuesday - Heres Why - TradingView
Google News at Macroaxis
over a month ago at news.google.com         
Individual investors account for 60 percent of Immutep Limiteds ownership, while institutions accoun...
Google News at Macroaxis
over a month ago at news.google.com         
Immutep ADR earnings missed, revenue topped estimates - Investing.com ZA - Investing.com South Afric...
Google News at Macroaxis
over three months ago at news.google.com         
Immutep Upcoming Signals For 2024 - Seeking Alpha
Google News at Macroaxis
over three months ago at news.google.com         
Immutep Limited Sees Significant Decline in Short Interest - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Immutep receives A2.6M RD tax incentive from French Government - Seeking Alpha
Google News at Macroaxis
over three months ago at news.google.com         
Immutep Expands Sites for Phase 1 Cancer Trial -November 22 ... - Marketscreener.com
Google News at Macroaxis
over three months ago at news.google.com         
Biotech stocks weather down market showing solid signs of recovery - Proactive Investors USA
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Immutep that are available to investors today. That information is available publicly through Immutep media outlets and privately through word of mouth or via Immutep internal channels. However, regardless of the origin, that massive amount of Immutep data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Immutep news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Immutep relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Immutep's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Immutep alpha.

Immutep Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
Check out Immutep Hype Analysis, Immutep Correlation and Immutep Performance.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Immutep Pink Sheet analysis

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Valuation
Check real value of public entities based on technical and fundamental data
CEOs Directory
Screen CEOs from public companies around the world
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Transaction History
View history of all your transactions and understand their impact on performance
Please note, there is a significant difference between Immutep's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immutep is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immutep's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.